$ARIA ARIAD PHARMACEUTICALS INC Insider Trading Week 39/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC in week 39/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Sell | S | 6.46 | 5,000 | 32,316 | 126,797 | 131.8 K to 126.8 K (-3.79 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 10,000 | 0 | 131,797 | 121.8 K to 131.8 K (+8.21 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 6.46 | 5,000 | 32,317 | 64,748 | 69.7 K to 64.7 K (-7.17 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 10,000 | 0 | 69,748 | 59.7 K to 69.7 K (+16.74 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 6.47 | 5,000 | 32,327 | 109,917 | 114.9 K to 109.9 K (-4.35 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 10,000 | 0 | 114,917 | 104.9 K to 114.9 K (+9.53 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | M | 0.00 | 17,500 | 0 | 17,500 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Sell | S | 6.46 | 8,750 | 56,551 | 289,231 | 298 K to 289.2 K (-2.94 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Buy | M | 0.00 | 17,500 | 0 | 297,981 | 280.5 K to 298 K (+6.24 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Sell | S | 6.46 | 5,500 | 35,503 | 122,224 | 127.7 K to 122.2 K (-4.31 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 10,000 | 0 | 127,724 | 117.7 K to 127.7 K (+8.49 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 17,500 | 0 | 17,500 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 6.46 | 8,750 | 56,560 | 334,086 | 342.8 K to 334.1 K (-2.55 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 17,500 | 0 | 342,836 | 325.3 K to 342.8 K (+5.38 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Sell | S | 6.46 | 5,000 | 32,316 | 240,449 | 245.4 K to 240.4 K (-2.04 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Buy | M | 0.00 | 10,000 | 0 | 250,449 | 240.4 K to 250.4 K (+4.16 %) |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | M | 0.00 | 47,500 | 0 | 47,500 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | A | 0.00 | 95,000 | 0 | 95,000 | |
| Sep 28 2015 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | M | 0.00 | 47,500 | 0 | 1,413,992 | 1.4 M to 1.4 M (+3.48 %) |